Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors

Eur J Med Chem. 2018 Feb 10:145:328-337. doi: 10.1016/j.ejmech.2018.01.008. Epub 2018 Jan 5.

Abstract

Using a dengue replicon cell line-based screening, we identified 3-(dimethylamino)propyl(3-((4-(4-fluorophenyl)-1-oxophthalazin-2(1H)-yl)methyl)phenyl)carbamate (10a) as a potent DENV-2 inhibitor, with an IC50 value of 0.64 μM. A series of novel phthalazinone derivatives based on hit 10a were synthesized and evaluated for their in vitro anti-DENV activity and cytotoxicity. The subsequent SAR study and optimization led to the discovery of the most promising compound 14l, which displayed potent anti-DENV-2 activity, with low IC50 value against DENV-2 RNA replication of 0.13 μM and high selectivity (SI = 89.2) with acceptable pharmacokinetics profiles.

Keywords: Dengue virus; Inhibitor; Optimization; Phthalazinone; SAR.

MeSH terms

  • Aedes / cytology
  • Aedes / virology
  • Animals
  • Antiviral Agents / chemical synthesis
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Cell Line
  • Dengue Virus / drug effects*
  • Dose-Response Relationship, Drug
  • Drug Discovery*
  • Humans
  • Male
  • Mice
  • Microbial Sensitivity Tests
  • Molecular Docking Simulation
  • Molecular Structure
  • Phthalazines / chemical synthesis
  • Phthalazines / chemistry
  • Phthalazines / pharmacology*
  • Structure-Activity Relationship
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Phthalazines